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Following liver transplantation, a series of 
events may take place that require rapid assessment 
and proper treatment in order to achieve good 
results (fable 1). Immediately after transplantation, 
an devation in the transaminases occurs that repre-
sents ischemic injury during the harvesting of the 
liver, during its placement in the recipient, ar both. 
The transaminases are in most cases less than 1000 
IV/mI, but may increase as high as 3000 IV/ml, 
depending on the extent of ischemic injury. Higher 
values than 3000 are certainly worrisome, since the 
extent of the damage may be so severe that the liver 
may not recover. The bilirubin, on the other hand, 
is usually lower than the preoperative levels due to a 
''wash out" phenomenon with the use of large 
quantities of fluid during the operation. In this 
situation in which multiple transfusions of red 
blood cells, platelets, plasma, and crystalloid are re-
Quired, the ischemic injury may not become ap-
parent until the second or third postoperative day 
when the transaminases reach the highest level. 
Approximately one-third of the patients have 
no further abnormalities of hepatic function, and in 
these cases the enzymes progressively return to 
normal. The rest of the patients, representing 
roughly two thirds, exhibit some manifestations of 
ongoing hepatic dysfunction, and, although mild in 
most cases, the abnormalities can lead to graft 
failure and sometimes death of the patient. We will 
discuss these complications in more detail. 
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of Pillsburgh Health Center, University of Pillsburgh, Pitts-
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TABLE 1. Causes of Graft Dysfunction Following 
Orthotopic Uv.r Transplantation 
I. Rejection 
2. Harvesting-induced injury 
3. Vascular thrombosis 
4. Infection 
S. Bile duct complications 
6. Hemolysis 
7. Drug-induced hepatic injury 
REJECTION 
Rejection is the most common cause of graft 
dysfunction. It is seen most often during the first 
three postoperative months, although it can occur 
at any time. Evidence of rejection is often noticed 
during the second or third week, but it has been 
documented as early as the third day after opera-
tion. The severity as well as the clincial picture are 
variable. Many patients become depressed and com-
plain of general malaise and lack of appetite. They 
may develop fever and abdominal pain. The graft 
may become firm and tender to palpation.' Eleva-
tions may occur in the transaminases, bilirubin, and 
alkaline phosphatase. Liver biopsy at this stage may 
help clarify the differential diagnosis. With early 
rejection, the portal tracts are infiltrated with cells 
that are largely lymphoid with a minor admixture of 
neutrophils and eosinophils. Bile ducts and particu-
larly the ductules show cytoplasmic vacuolation and 
the presence of inflammatory cells (Fig. 1). Rejec-
tion may develop with slow and progressive graft 
dysfunction, or it may present acutely in a more 
aggressive form, characterized by a rapid increase in 
the bilirubin and transaminases. The latter is more 
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FIG. 1. early reJection. A: The portal area is expanded by an infiltrate, predominantly lymphoid. Bile ductules appear more cellular 
than normal. (Trichrome, x 197.1 B: The bile ductules are surrounded by lymphocytes, a few of which have breached the basement 
membrane. The cells are $WOllen and vacuolated. Hapatocytes at the limiting plate are, at this stage, unaffected. (PAS-diastase, 
x 470.1 
difficult to treat and, frequently, retransplantation 
is the only method of therapy. 
As described elsewhere in this issue of 
Seminars, treatment consists of increasing doses of 
steroids, the administration of monoclonal anti-
lymphocyte globulin (ALG), or both. The dosage of 
steroids depends in part on the size of the patient 
and the severity of the rejection. For example, in an 
adult with mild rejection, 1 gm of prednisolone 
intravenously may suffice, but if the rejection is 
more severe, the pulse of steroids should be fol-
lowed by a 5-day burst of prednisolone or predni-
sone, starting at 200 mg and stopping at a mainte-
nance dose of 20 mg/day. A similar situation in 
children will be treated with 1 gm of hydrocortisone 
followed by a tapering dose of prednisolone over S 
days, starting at 100 mg and stopping with a main-
tenance dose of 20 or 10 mg/day. If rejection 
cannot be reversed, then a 10- or 14-day course with 
monoclonal ALG is indicated. 
A disturbing combination of problems is that 
of cytomegalovirus (CMV) infection in the presence 
of rejection, since the goal of therapy is completely 
different with these two complications. Reduction 
of immunosuppression is indicated for a CMV in-
fection, whereas an increase of immunosuppression 
is required to control rejection. In fact, the most 
common sequence of events is to have a patient 
who has been treated for an episode of rejection 
then develop CMV infection_ A liver biopsy at this 
time may show the presence of intranuclear or 
intracytoplasmic inclusion bodies as well as the fea-
ture characteristic of rejection (Fig. 2). It has been 
possible to treat the majority of these patients by 
decreasing maintenance immunosuppression and by 
giving weU-timed pulses of steroids. This problem 
may be made easier in the future, since new drugs 
for CMV infection are under investigation at the 
present time. 
ISCHEMIC INJURY 
The causes of ischemic injury during the har-
vesting or in the recipient's operation or both are 
listed in Table 2. Initially, there is little trouble in ' 
making the diagnosis. There is marked and progres-
gressive elevation of the bilirubin, and serum 
transaminase increases are always in the thousands. 
Severe coagulopathy, hypoglycemia, and renal 
failure are also observed. The patients exhibit vary-
ing degrees of encephalopathy. 
Liver biopsy at this stage may distinguish be-
tween rejection (Fig. I) and the features of harvest-
ing-related injury (Fig. 3). A word of caution is in 
order. The features of early vascular injury may be 
peripheral and subcapsular in distribution so that a 
superficial biopsy may not be representative of the 
entire liver and may provide a pessimistic histologic 
picture. On occasion, liver function may recover; 
however, retransplantation is the only hope in the 
majority of these patients. The I-year survival rate 
following retransplantation for ischemic injury is 
only 20070 compared with 60% for chronic rejection 
or arterial thrombosis. 
If it is decided, as an option to retransplanta-
tion, to hope for recovery from ischemic damage, 
the supervention of rejection is always a possibility 
and one that cannot be assessed easily, even with 
serial biopsies and the most careful attention to 
liver function tests. 
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FIG. 2. Cytomegalovirus hepatitis. A: CMV can be presented 
in the presence of portal features of rejection. The CMV (arrows) 
is not responsible for the portal cells, often being seen without 
any portal infiltrate. (H&E, x 197.) B: Infected cells have the 
nuclear inclusion but just as characteristic is the glossy 
cytoplasm with bright eos;nophilic granular inclusions (H&E, X 
470.) C: TIny neutrophilic microabscesses in the hepatiC lobule 
are often the first clue to the presence of cytomegalovirus (CMV) 
which may be sparse. (H&E, x 470.) Enzyme-antibody reaction 
using a commercially available antibody to CMV reveals a cyto-
plasmic antigen in the infected cells (inset). (Peroxidase-DAB, 
x 470.) 
VASCULAR THROMBOSIS 
Thrombosis of the hepatic artery is a common 
cause of graft dysfunction particularly in children.2 
The incidence is approximately 1.5 and 11.8070 in 
adults and children, respectively, Arterial thrombo-
sis is the second most common cause for retrans-
plantation in the pediatric populatoin. 
Many patients develop a temperature spike, 
usually 39° or 40°C, preceded by shaking chills. 
There is frequently mild to moderate elevation of 
the transaminases, although loss or reduction of the 
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liver-based synthetic processes does not necessarily 
follow. 
Thrombosis of the artery may lead to regional 
necrosis of the liver and abscess formation. Necro-
sis of the bile duct may also occur with leakage and 
bile peritonitis from which bacteria can be cultured. 
The most common offending organisms belong to 
the anaerobic and enteric groups. 
The diagnosis of an arterial thrombosis can be 
made at an early time by keeping a high index of 
suspicion. A roentgenogram of the thorax may 
show gas-forming abscesses within the liver 
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TABLE 2. Causes of Graft Ischemia 
1. Un\tahlc dOllor (h)potCIlSIOIl. \,a'<)prc"ors) 
2. Inadequate prc'cr\ation 
J. Prol(lngcd cold i"hemia 
4. Prnlonged warm Ischemia 
FIG. 3. Early harvesting injury. injury in the earty period is 
characterized by centriiobular hepatocyte swelling and canali-
cular cholestasis. Periportal cells are preserved or even shrunken 
and acidophilic. Portal areas are inconspicuous (H&E. x 100.) 
parenchyma. An ultrasound or a computed tomog-
raphy (CT) scan give additional information about 
the extent of the injury. A doppler ultrasound has 
been very useful in determining the patency of the 
artery and portal vein. If the artery cannot be seen 
to pulsate, a selective angiogram is mandatory. The 
treatment of choice is retransplantation, although a 
few patients have survived with dearterialized livers. 
The experience with this serious complication at the 
University of Pittsburgh is reviewed elsewhere in 
this issue of Seminars. 
INFECTION 
Bacterial, fungal, and viral infection can also 
lead to hepatic dysfunction following transplanta-
tion.3.4 Viral infections may create especially 
serious problems in diagnosis and treatment, since 
they can infest and damage the grafts directly at 
variable and unpredictable times. Virus infections, 
of the herpes group (CMV, herpes simplex, Epstein-
Barr virus, and herpes zoster) have been seen fre-
q uently. 3 A ttacks by t he hepatitis virus usually 
occur 2 or 3 months after transplantation. The fol-
lowing cases will demonstrate some of the clinical 
features of these viral infections. 
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Case 1: Varicella Infection 
OT 368, a 4-year, IO-monlh-old South Ameri-
can girl, underwent an orthotopic liver transplanta-
tion at the age of 4 years, 5 months. She had cir-
rhosis secondary to biliary atresia. She did well for 
5 months until 5 days before her last admission 
when she entered a hospital in Caracas with a vesi-
cular rash consistent with varicella. She was trans-
ferred to Pittsburgh for further treatment. 
On physical examination, skin lesions of vari-
cella were found mostly on the trunk and face, but 
also on the buttocks and right leg. The prothrombin 
time was 32.5 seconds with a control of 11.5 and 
the partial thromboplastin time was 58 seconds with 
a control of 26.5 seconds. The total and direct bili-
rubin were 5.3 and 3.7 mgldl, respectively. The 
SOOT was 5890 lUll; SGPT was 4389 IU/I; alka-
line phosphatase was 348 lUll; and gamma gluta-
my I transpeptidase (GGTP) was 629 lUll. The pa-
tient was hypotensive and in severe respiratory 
distress. Her course was one of rapid deterioration 
despite aggressive treatment and she died a few 
hours later. The autopsy revealed massive hepatic 
necrosis. Histologically, there were numerous intra-
nuclear inclusion bodies in the periphery of the 
necrotic areas (Fig. 4). Varicella hepatitis has been 
described before as a cause of earlyS and late6 
death after liver transplantation. 
Case 2: CMV Hepatitis 
OT 472, a 7-year-old white girl with biliary 
atresia, underwent an orthotopic liver transplanta-
tion on December 7, 1984. She developed severe re-
jection on the fourth postoperatie day, requiring 
treatment with increased steroids and monoclonal 
ALG (OKT3). Four weeks later, she developed a 
fever of 4O.5°C; marked elevation of the enzymes 
from previously normal values; increases of the 
total and direct bilirubin to 3.8 and 2.9 mg/dl; and 
increased levels of SaOT, SGPT, and GOTP to 
845, 588, and 534 lUll, respectively. CMV was iso-
lated from urine, throat, bronchi, and blood. A 
liver biopsy re\"ealed lobular hepatitis with multiple 
microabscesses. Numerous intranuclear and intra-
cytoplasmic viral inclusions were noted similar to 
those in Figure 2. CMV was also isolated from the 
liver tissue. Treatment consisted of reduction of 
immunosuppression with a good response. The pa-
tient was discharged with normal liver function 
tests. 
Cultures taken from throat washings, urine 
samples, blood buffy coats, and liver biopsies have 
aided in the diagnosis of these viral infections. 
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FIG. 4. Varicella hepatitis. At the margins of the necrotic 
lones, there were multinucleated hepatocytes and cells with 
waxy or eosinophilic intranuclear inclusions (arrow). (H&E. x 
450,) 
Fungal infections have been seen in liver transplant 
recipients and Candida has been the most common 
organism isolated.4 Septicemia with gram-negative 
and gram-positive organisms may also caw.se hepatic 
dysfunction. 
BilE DUCT COMPLICATIONS 
Complications with bile duct reconstruction 
used to be very common. Although these have been 
minimized with the standardization of reconstruc-
tive techniques, bile leak or biliary obstruction are 
important causes of hepatic dysfunction.7 An 
internal bile leak usually is manifested by acute 
peritonitis associated with mild elevations of the 
bilirubin and enzymes. Biliary leaks caused by bile 
duct disruption usually occur within 10 days after 
surgery. Drainage of bile may be present in the ab-
dominal drains. T -tube cholangiogram, paraiso-
propyl iminodiacetic acid (PIPIDA) scan, and ultra-
sound are useful methods for making the diagnosis. 
The treatment consists of reoperation with repair of 
the bile duct disruption. 
Stenosis of the bile duct is frequently associated 
with acute cholangitis characterized by fever, jaun-
dice, and elevation of the transaminases. Bacteria 
indigenous to the gastrointestinal tract often can be 
cultured from the blood. Ultrasound may disclose 
dilated extrahepatic or intrahepatic bile ducts. The 
diagnosis is confirmed by percutaneous cholangiog-
raphy or endoscopic retrograde pancreaticocholan-
giography (ERCP). This complication can usually 
be treated by intraluminal dilation via a percutane-
-'I.) 
ou" catheter, but in some ca~es surgical correction is 
necessary. 
HEMOLYSIS 
Hemolysis has been observed in many patients 
after hepatic transplantation. At the University of 
Pittsburgh, approximately 17f1io of the patients re-
ceived ABO-unmatched transplants. These patients 
may develop hemolysis with an increase in the direct 
and indirect bilirubin associated with a decrease in· 
the hematocrit value in the absence of hemorrhage. 
It has been well documented that liver grafts from 
donors having ABO types different from the reci-
pient can produce anti recipient ABO antibodies that 
have been detected from 8 to 16 days after trans-
plantation and that persist for as long as 41 days 
postoperatively.8 
DRUG-INDUCED HEPATIC INJURY 
It is beyond the scope of this article to discuss 
all drugs responsible for hepatic dysfunction; in 
fact, with the advent of new sensitive tests, almost 
all drugs have been found to be associated with 
liver injury. The two mechanisms by which drugs 
can cause hepatic injury are direct toxicity and 
hypersensitivity. Most of the industrial agents 
responsible for liver injury do so by direct toxicity, 
that is, mushrooms and chlorophenothane (DDT). 
Halothane and phenytoin are drugs that may pro-
duce hepatic injury by hypersensitivity. 
The diagnosis of a drug-induced injury is 
usually one of exclusion. In liver recipients, some of 
the most commonly used drugs that may be associ-
ated with hepatic dysfunction are listed in Table 3. 
A liver biopsy is usually not helpful, since the 
pattern of injury is variable and not specific. The 
hepatic dysfunction usually resolves when the of-
fending drug is withdrawn. 
Cyclosporine may cause hepatic dysfunction in 
renal allograft recipients.9 Approximately 20070 (13 
patients) of the 66 patients studied had at least one 
episode of hepatic dysfunction characterized by an 
elevation of bilirubin over 2.0 mg/dl. Three of the 
these 13 cases had evidence of late toxicity that 
reversed after reduction of the dosages. In none of 
the renal patients with early reactions was the 
toxicity severe enough to warrant withdrawal of the 
drug. Hepatotoxicity in liver recipients is difficult to 
diagnosis and, in fact, an erroneous diagnosis may 
precipitate a rejection episode by an unwise reduc-
tion or discontinuance of the cyclosporine dose. 
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TABLE 3. Frequently Used Drugs in Hepatic 
Transplantation that May Be Associated 
with Hepatic Dysfunction 
1 mm U !1o,upprc\Sants 
CIdo~porine 
Azathioprine 
Antihvpertemive and dillr~tir agents 
Methyldopa 
Hydralazine hydrochloride 
Captopril 
Clonidine hydrochloride 
Ethacrynic acid 
Antimicrobial agents 
Penicillins (particularly synthetic compounds) 
Cephalosporins 
Erythromycin 
Clindamycin 
Aminoglycosides 
Amphotericin B 
Flucyt osine 
Trimethoprim-sulfamethoxazole 
• 
The morphologic representation of cyclosporine 
toxicity in the liver is not established. 
Azathioprine has also been reported to induce 
hepatic injury in a few renal transplant pa-
tients. IO•11 The diagnosis of hepatic dysfunction 
mduced by non immunosuppressive drugs in liver 
recipients is also difficult, if not impossible. Certain 
drugs should be viewed with extra suspicion. For 
example, methyldopa is known to induce hepatic 
damage that may vary from mild periportal inflam-
mation to acute hepatitis. Symptoms of actue hepa-
titis resemble those of acute viral hepatitis. There is 
elevation of the bilirubin and transaminases, but the 
serum alkaline phosphastase activity is normal. 
Mortality approaches IOOJo in those patients who 
develop clinical jaundice. 12 
An occasional report on hydralazine-induced 
hepatic dysfunction has appeared in the literature, 
but the evidence has not been conclusive. Most of 
the antibiotics have been associated with hepatic 
dysfunction, and perhaps chloramphenicol is the 
safest in relation to liver injury. Diphenylhydantoin 
was the cause of acute fulminant hepatitis leading 
to the liver transplantation of one of our patients, 
but hepatic dysfunction induced by this drug after 
transplantation has not been diagnosed. 
,.. )44· '0(24UO 
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SUMMARY 
Numerous causes can lead to hepatic dysfunc-
tion following orthotopic livertranspJantation. The 
most common cause is rejection, which is usually 
nonpreventable. The clinical presentation, time of 
onset, and eYen treatment are variable. Other 
causes, such as perioperative ischemic injury, vascu-
lar thrombosis, and complications of bile duct 
reconstruction may be preventable with good surgi-
cal technique. Infections can also be minimized by 
careful adjustment of immunotherapy, avoidance 
overimmunosuppression, and the judicious use of 
antibiotics. Hepatic dysfunction following ortho-
topic Ivier transplantation requires rapid assessment 
and proper treatment in order to prevent serious 
and possibly fatal complications. 
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